Illumina Inc
Illumina Inc. specializes in the development, manufacturing, and marketing of integrated systems for the analysis of genetic variations and biological functions.
Price history of Illumina Inc
Price history of Illumina Inc
Performance & Momentum
Strategic Analysis
Illumina Inc • 2026
Illumina is a leading player in DNA sequencing and genomic analysis solutions, with a business focused on instruments, consumables, and software supporting research and clinical applications. Its positioning is built on a technologically difficult-to-replicate base and a central role in the industrialization of genomics.
- Recognized leader in a niche market with high technological barriers
- Business model supported by recurring revenue from consumables and the installed base
- Structural exposure to the rise of precision medicine and genetic research
- Cyclical visibility on investment spending by laboratories and institutional clients
- A stock market history still marked by a sharp long-term correction, reflecting more cautious expectations
Momentum is clearly positive, with a strong recent trend reflecting a renewed interest from investors after a prolonged period of underperformance. Strategically, this suggests a stock that is back in favor, but still needs to be confirmed by a lasting improvement in confidence around commercial execution and underlying growth.
Similar stocks to Illumina Inc
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
